Integrative Physiology |
From the Department of Cardiovascular Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, Mich.
Correspondence to Dr Mark Rekhter, Department of Cardiovascular Therapeutics, Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Rd, Ann Arbor, MI 48105. E-mail mark.rekhter{at}wl.com
| Abstract |
|---|
|
|
|---|
Key Words: arteriosclerosis cholesterol collagen macrophage plaque rupture
| Introduction |
|---|
|
|
|---|
The following mechanism has been proposed4 : hypercholesterolemia induces macrophage accumulation and activation in the atheroma; macrophages synthesize and secrete proteolytic enzymes, matrix metalloproteinases (MMPs); MMPs destroy collagen, thereby weakening the plaque. Although this mechanism looks very plausible, several key questions remain. First, the changes in plaque mechanical properties have long been assumed, although never directly demonstrated. Second, the most convincing evidence of the link between lipids and collagen was obtained in reverse sequence, when lipid lowering led to collagen accumulation in rabbit atheroma.5 It still remains to be seen whether lipid accumulation induces collagen breakdown. Third, collagen content is a net result of its degradation and synthesis. The role of collagen synthesis in plaque destabilization has not yet been addressed. Fourth, tissue mechanical properties depend not only on collagen content, but also on its cross-linking and distribution.6 These factors have not been studied in the context of plaque rupture.
We have recently described an animal model of
atherosclerosis in which a plaque, formed around an
inflatable balloon (Figure 1
), can be
ruptured at will.7 In the current study, rupturing
pressure was used to measure plaque mechanical strength. We have tested
the hypothesis that hypercholesterolemia
induces local collagen loss and subsequent plaque mechanical
destabilization. We report
hypercholesterolemia-induced plaque weakening
associated with changes in collagen content, architecture, and
turnover. These data provide the first direct measurement of reduced
mechanical strength in lipid-rich plaques and suggest a mechanism for
their destabilization that leads to acute coronary events.
|
| Materials and Methods |
|---|
|
|
|---|
Our model of plaque rupture has been recently described.7
Catheters with matrix-covered balloons (Figure 1
) were implanted
into the aorta of rabbits fed standard or 0.5% cholesterol
chow (n=70). Balloon coverage facilitated plaque formation and served
as a substrate to evaluate in vivo collagenolytic activities. Animals
were euthanized 1, 2, and 3 months after catheter implantation. The
pressure needed to rupture the plaque by balloon inflation was used as
an index of plaque strength. All procedures that used animals were
conducted in compliance with state and federal laws, as well as
guidelines established by the Parke-Davis Animal Care and Use
Committee.
Tissue cholesterol, cholesterol esters, triglycerides, and phospholipids were quantified using HPLC and evaporative light-scattering mass detection. Hydroxyproline (a measure of collagen) and pyridinoline (a measure of collagen cross-linking) were determined by tandem mass spectroscopy. To detect gelatinolytic and caseinolytic activities, plaque lysates underwent gel zymography. Sirius red staining was used to identify interstitial collagen. Cellular composition and collagen synthesis were characterized immunocytochemically with subsequent morphometric analysis. Two-way ANOVA was used to analyze the data.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
The collagen-wrapped balloons were firmly attached to the aortic wall
and were covered with fibrotic tissue in all animals, regardless of the
diet. However, balloon-associated lesions were bigger in
cholesterol-fed animals (Table 1
). Free cholesterol and
cholesterol esters accumulated in the plaques of
cholesterol-fed rabbits in a time-dependent manner and
significantly exceeded respective concentrations in the lesions of
chow-fed animals (Table 2
). Phospholipid
content was also higher in hypercholesterolemic
rabbits, although it did not significantly change over time.
Triglyceride accumulation did not differ among the
experimental groups (Table 2
).
|
|
Rupturing Pressure
Balloon-associated plaques were ruptured ex vivo by inflation of
intraplaque balloons. Representative pressure-volume
curves obtained from 3-month-old plaque-covered balloons are
illustrated in Figure 2
. A notable
inflection in the trace coincided with the balloon opening, and plaque
fracture was observed visually. Plaque-rupturing pressure did not
significantly change over time in chow-fed rabbits, whereas it
gradually decreased in cholesterol-fed rabbits (Figure 3
). At 3 months, the rupturing pressure
in cholesterol-fed rabbits was 40% less than in the
standard chow-fed rabbits. Thus, the cholesterol diet
reduced plaque mechanical strength in a time-dependent manner.
|
|
Analysis of video images revealed that the weakening of the
plaque was associated with changes in the location of the fissure. In
chow-fed rabbits, the fissure site averaged 2.5 to 3 arbitrary units at
each of the 3 time points (Figure 4
).
This indicates that on average plaque fissures occurred midway between
the plaque cap and base region. Plaque fissures also occurred at the
midpoint in 1- and 2-month-old plaques from
high-cholesterol rabbits. However, by the third month, the
fissure site had shifted toward the base, ie, shoulder region, as
indicated by the increase to 4.6 arbitrary units. The shift in the
fissure location to the base of the plaque was coincident with a
reduction in rupturing pressure. This strongly suggests the local
nature of plaque weakening.
|
Collagen Content and Cross-Linking
Tissue mechanical strength is dependent on collagen content and
cross-links between collagen molecules. Plaque collagen content was
expressed as hydroxyproline concentration, whereas collagen
cross-linking was characterized by the ratio of pyridinoline to
hydroxyproline. In the standard chow group, hydroxyproline
concentration did not change over time. In the
cholesterol-fed group, there was a significant,
time-dependent decrease in hydroxyproline content (Figure 5A
). The degree of collagen
cross-linking did not differ between standard chowfed and
cholesterol-fed groups. However, in both groups, the
pyridinoline/hydroxyproline ratio increased in a time-dependent manner.
At 3 months, both lipid-poor and lipid-rich plaques had a significantly
higher ratio than their respective 2-month-old lesions (Figure 5B
). Progressive elevation of pyridinoline bonds most likely
reflects collagen maturation and appears to be diet independent. Thus,
plaque weakening was associated with an overall collagen loss, but not
with a deficiency in the number of collagen cross-links.
|
Collagen Distribution
In our model, balloon-associated plaques contain 2 collagen pools
(Figure 1
): the first pool contains "old" collagen, which
was originally wrapped around the balloon, and the second pool contains
"new" collagen, a product of plaque smooth muscle cells (SMCs),
that occupied the lesion periphery. In the standard diet group, old
collagen was preserved over the 3-month period, and new collagen
accumulated in a time-dependent fashion. In contrast, lipid-rich
plaques exhibited time-dependent collagen loss in the shoulder region,
whereas old collagen was preserved and new collagen accumulated in the
fibrous cap (Figures 5C
, 5D
, and 6
). The presence of old collagen is a
unique feature of this model. It served as a substrate for accumulated
in vivo collagenolytic activities, thereby enabling unequivocal
interpretation of histological data (any hole in the
old collagen layer was interpreted as a signature of local collagen
breakdown). Local collagen loss in the shoulder area corroborates our
data on preferential localization of plaque fissures.
|
Cellular Composition
Plaques from standard chow rabbits contained very few
macrophages, whereas macrophage accumulation was a
prominent feature of lipid-rich lesions (Table 1
). In both
groups, the number of macrophages did not significantly change
over time (Table 1
). In lipid-rich plaques, the vast majority of
macrophages were located in the shoulder areas, whereas fibrous
caps were virtually macrophage-free (Figure 6
).
SMCs progressively accumulated in the lesions of standard
chowfed rabbits and reached plateau at 2 months after catheter
implantation (Table 1
). They evenly occupied both cap and
shoulder regions (Figure 7
). In the
cholesterol-fed group, the number and distribution of SMCs
did not differ from their standard chow counterparts at 1 month.
However, at 2 months the number of SMCs in cholesterol-fed
group did not increase and was significantly less than in standard chow
group. At 3 months, the number of SMCs in the
cholesterol-fed group dramatically dropped and became
significantly smaller than both 2-month cholesterol-fed and
3-month standard chowfed counterparts (Table 1
). SMC loss took
place almost exclusively in the plaque shoulders (Figure 7
). It
is likely that observed loss of actin-positive SMCs may be at least
partially attributed to changes in SMC phenotype. However, the
simultaneous decrease in the number of
immunostainable SMCs, increase in the number of
immunostainable macrophages, and decrease in total
cell number (Table 1
) are indicative of true SMC loss.
|
We did not find a statistically significant difference in microvessel
density between standard and cholesterol-fed rabbits at any
time point (Table 1
). Hemosiderin depositions
were found in both types of lesions with relatively equal frequency.
These facts most likely reflect the specifics of our animal model and
do not necessarily uncover the role of plaque microvessels and
associated hemorrhages in human plaque rupture.
Thus, local collagen loss in lipid-rich plaques was spatially and temporally associated with macrophage accumulation and SMC depletion, whereas in this animal model it did not appear to be microvessel-dependent.
Collagen Synthesis
One month after catheter implantation, lesions from both groups
contained similar numbers of procollagen-positive cells (Table 1
). Plaques from standard chowfed rabbits contained fewer
collagen-producing cells at 2 months and exhibited almost no synthetic
activity at 3 months (Table 1
, Figure 7
). In contrast,
the number of procollagen-positive cells dramatically increased in
2-month-old, lipid-rich plaques. At 3 months, lipid-rich lesions were
still characterized by a significant number of collagen-synthesizing
cells, although the number of positive cells was lower than that at 2
months (Table 1
, Figure 7
). Both plaque caps and
shoulders displayed procollagen positivity. The relative decline in
collagen production between 2 and 3 months was associated with
local (in the shoulder area) loss of SMCs, a predominant source of
collagen in atherosclerotic plaques. Thus, lipid accumulation in the
plaque was associated with a severe loss of SMCs. The remaining SMCs
showed increased collagen synthesis, although it was insufficient to
counterbalance collagen degradation and SMC loss.
MMP Activity
Because the most dramatic collagen loss in lipid-rich plaques was
detected at 3 months, gel zymography studies were limited to the
3-month group. Negative control samples (normal rabbit aorta) exhibited
gelatinolytic activity at 72 kDa (proMMP-2) only
and no caseinolytic activity (Figure 8
).
In contrast with normal aorta, both types of plaques also displayed
gelatinolytic activity at 92 kDa (proMMP-9) and
68 kDa (active MMP-2), as well as caseinolytic activity at 57 kDa
(proMMP-1 or 3), 45 kDa (active MMP-1 or -3), and 19 kDa (active
matrilysin) (Figure 8
). As shown in Table 3
, we found modest but statistically
significant enhancement of gelatinolytic activity
at 92 and 72 kDa, as well as caseinolytic activity at 57, 45, and 19
kDa in the lipid-laden plaques compared with plaques from standard
chowfed rabbits. It is still unknown, however, whether these
activities are solely responsible for plaque collagen degradation.
|
|
| Discussion |
|---|
|
|
|---|
Hypercholesterolemia is a risk factor for plaque rupture and myocardial infarct.2 Plaque rupture occurs when external mechanical forces exceed the tensile strength of vulnerable regions of the plaque.1 It is implied, although never directly shown, that vulnerable plaques are mechanically weak. Our data are the first to demonstrate a causal relationship between hypercholesterolemia and plaque mechanical destabilization. Moreover, we have shown that dietary manipulation can be used to engineer both "stable" and "unstable" plaques, and rupturing pressure may be a measure of plaque stability.
Mechanical strength of atherosclerotic plaques is primarily determined by fibrillar collagen, specifically by collagen content, cross-linking, and distribution.6 We demonstrated a time-dependent decrease of overall collagen content in lipid-rich plaques, whereas the level of cross-linking did not differ between high- and low-cholesterol groups. These results indicate that collagen loss, rather than defective assembling, is most likely responsible for plaque destabilization. It still needs to be determined why a relatively modest decrease in collagen content led to a significant impairment of plaque strength. The functional consequences of collagen loss may be highly dependent on the local nature of this phenomenon. We found that collagen loss occurred primarily in plaque shoulders. It is feasible that the interface between highly cross-linked (ie, hard) collagen in the cap and the virtually collagen-free (ie, soft) shoulder creates a local stress concentration that rendered plaques prone to rupture. Preferential location of the fissures in the shoulders of lipid-rich lesions, which has been demonstrated in human plaques8 and reproduced in our animal model, corroborates this hypothesis.
A mechanistic link between hypercholesterolemia and collagen loss is still hypothetical, although a critical role of macrophages, as the major source of MMPs and other proteolytic enzymes, has been strongly suggested.4 9 Although our data do not elucidate the definitive mechanism of collagen degradation, observed temporal and spatial associations between lipid deposition, macrophage accumulation, and collagen breakdown present strong circumstantial evidence that hypercholesterolemia leads to plaque weakening via macrophage-dependent collagen degradation. At the same time, our data suggest that MMPs may not be solely responsible for macrophage-driven collagen breakdown. Those proteolytic enzymes playing a major role in plaque collagen degradation have yet to be identified. As in the case of other phenomena associated with inflammatory infiltrates, increased lytic activity may be very focal. Although such localized phenomena could significantly change the dynamics of the local environment, the effect would be lost when averaged at the tissue scale. The mechanism by which hypercholesterolemia leads to expression and/or activation of relevant proteolytic enzymes is another unknown.
Recently, Aikawa et al5 demonstrated that lipid lowering reduced MMP activity and increased collagen content of the rabbit atheroma. Our findings complement these data, although MMP changes in our model were not as dramatic. Taken together, both studies show the same phenomenon from the perspective of collagen loss caused by lipid accumulation and by collagen preservation as a result of lipid lowering.
Collagen content is the net result of its synthesis and degradation. As discussed above, collagen degradation was prominent in lipid-rich lesions. Interestingly, we have demonstrated that collagen production was also increased in these lesions. We found type I procollagen-synthesizing cells in both fibrous caps and shoulders. However, collagen breakdown prevailed in the shoulders and led to an overall local collagen loss. Thus, even enhanced collagen production was insufficient to replenish its breakdown. Because virtually every SMC in the shoulders was procollagen-positive, but the number of SMCs decreased, it appears that this relative deficiency of collagen production was determined by local SMC depletion. At the same time, lack of collagen degradation in the cap area combined with increased synthesis led to overall collagen accumulation. These results show that in our model, (1) hypercholesterolemia simultaneously stimulated plaque growth and destabilization, and (2) destabilization was determined by collagen breakdown combined with local loss of cellular source of collagen synthesis, rather than by inhibition of collagen gene expression. It remains to be determined how hypercholesterolemia led to SMC loss, although induction of SMC apoptosis is likely. It was demonstrated that SMCs undergo apoptosis in rabbit atherosclerotic plaques and that cholesterol withdrawal inhibits apoptosis.10
Thus, we have demonstrated that hypercholesterolemia induced local collagen loss and plaque destabilization. Identification of molecular mechanisms of this phenomenon may generate new targets for pharmacological plaque stabilization and prevention of acute coronary events.
| Acknowledgments |
|---|
Received July 23, 1999; accepted October 8, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. K. Nadkarni, M. C. Pierce, B. H. Park, J. F. de Boer, P. Whittaker, B. E. Bouma, J. E. Bressner, E. Halpern, S. L. Houser, and G. J. Tearney Measurement of Collagen and Smooth Muscle Cell Content in Atherosclerotic Plaques Using Polarization-Sensitive Optical Coherence Tomography J. Am. Coll. Cardiol., April 3, 2007; 49(13): 1474 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Buttice, J. Miller, L. Wang, and B. D. Smith Interferon-{gamma} Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells Circ. Res., March 3, 2006; 98(4): 472 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Nadkarni, B. E. Bouma, T. Helg, R. Chan, E. Halpern, A. Chau, M. S. Minsky, J. T. Motz, S. L. Houser, and G. J. Tearney Characterization of Atherosclerotic Plaques by Laser Speckle Imaging Circulation, August 9, 2005; 112(6): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Burke, R. Virmani, Z. Galis, C. C. Haudenschild, and J. E. Muller Task force #2--what is the pathologic basis for new atherosclerosis imaging techniques? J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1874 - 1886. [Full Text] [PDF] |
||||
![]() |
B. Schieffer Interaction of interleukin-6 and angiotensin II in atherosclerosis: culprit for inflammation? Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A25 - A30. [Abstract] [PDF] |
||||
![]() |
M. D. Rekhter How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res, April 1, 2002; 54(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Galis and J. J. Khatri Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly Circ. Res., February 22, 2002; 90(3): 251 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aikawa and P. Libby Vascular inflammation and activation: new targets for lipid lowering Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B3 - B11. [Abstract] [PDF] |
||||
![]() |
S. G. Velleman, R. J. McCormick, D. Ely, B. B. Jarrold, R. A. Patterson, C. B. Scott, H. Daneshvar, and W. L. Bacon Collagen Characteristics and Organization during the Progression of Cholesterol-Induced Atherosclerosis in Japanese Quail Experimental Biology and Medicine, April 1, 2001; 226(4): 328 - 333. [Abstract] [Full Text] |
||||
![]() |
Y. Fukumoto, P. Libby, E. Rabkin, C. C. Hill, M. Enomoto, Y. Hirouchi, M. Shiomi, and M. Aikawa Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits Circulation, February 20, 2001; 103(7): 993 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Galis Atheroma Morphology and Mechanical Strength : Looks Are Important, After All--Lose the Fat Circ. Res., January 7, 2000; 86(1): 1 - 3. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |